Local ablative therapy improves overall survival in patients with limited oligometastatic disease. Single fraction SBRT is efficient and is safe in several body sites and can provide a high rate of local control, with 20Gy in 1 fraction commonly used in Europe. However, treating metastases in the abdomen is difficult due close proximity to mobile luminal organs and poor visualization on cone beam CT. The purpose of this study is to determine the feasibility of delivering MR-guided adaptive stereotactic body radiation therapy (SBRT) in a single fraction for abdominal metastases. Patients with abdominal metastases within 8mm from luminal organs treated with hypofractionation or SBRT using maximum inhale breath hold (MIBH) respiratory gating on an integrated MR-Linac or MR-cobalt radiotherapy system were retrospectively analyzed. Single fraction SBRT plans were created on the original MRI simulation with dose constraints from the AAPM Task Group 101 and Timmerman et al. Optimized PTVs (PTVopt) created by a Boolean subtraction of the 3-5mm expansion around luminal organs from the 3mm expansion around the GTV. Using a prescription of 24Gy in 1 fraction, goals included PTV V95% > 90%, PTVopt V95% > 90%, and PTVopt D99% > 20Gy with no OAR dose violations. The single fraction plans were tested on 5 fractional MRI scans. Dosimetric data was collected with the original plan (“predicted”) and after the plan was adapted using an isotoxic approach to the daily re-contoured luminal organ anatomy (“Re-optimized”). The Wilcoxon rank sum test was used to compare dosimetric data and the frequency of meeting dosimetric goals between the multi-fraction and single fraction baseline plans and between the predicted and re-optimized fractional plans. Ten patients with abdominal metastases (4 liver, 3 lymph node, 2 kidney, and 1 adrenal site) with GTV mean and range of 25.5 (1.64, 84.2) mL of various histologies were analyzed. The multi-fraction and single fraction plans mean PTV V95% and PTVopt V95% were 89.7% vs. 81.5% and 97.0% vs. 90.9% respectively (all p>0.05), while 2/10 of both the multi-fraction and single fraction plans had a PTVopt V95% < 90%, and no OAR dose constraints were violated. Comparing the predicted and re-optimized fractional plans, there was a statistically significant, 32.8% increase in the mean PTVopt D99% and 68% decrease in the mean frequency of OAR dose violations (Table 1). Single fraction SBRT for the treatment of abdominal metastases with online adaptive MR guidance is feasible and may be an efficient alternative to multi-fraction treatments. Online MR-guided adaptation is required to maintain adequate target coverage while respecting OAR dose constraints.Abstract 2406; TableTable 1: Isotoxic OptimizationMeanFrequencyPTV V95% (%)PTVopt V95% (%)PTVopt D99% (Gy)PTV V95% > 90%PTVopt V95% > 90%PTVopt D99% > 20GyOAR ViolationsPredicted81.187.917.40.240.680.240.68Re-optimized84.892.822.60.420.820.740p-value0.680.310.01*0.160.360.01*0.001* Open table in a new tab